Medicine and Dentistry
Patient
100%
Diffuse Large B-Cell Lymphoma
81%
Lymphoma
50%
Cohort Analysis
44%
Therapeutic Procedure
37%
Inpatient
33%
Chemotherapy
29%
Peripheral T-Cell Lymphoma
28%
Gene
22%
Diagnosis
21%
Multiple Myeloma
21%
Clinical Trial
19%
Malignant Neoplasm
17%
Evaluation Study
16%
B Cell
15%
Hospital
15%
Proportional Hazards Model
15%
Analysis
15%
Incidence
14%
Hemoglobin
14%
Venous Thromboembolism
14%
Thymus
14%
Work Disability
14%
Agents Acting on the Eye
14%
Personalized Medicine
14%
Cancer Cell Line
14%
Development
14%
Neutrophil
14%
Memory B Cell
14%
Hematological Cancer
14%
Drug Effect
14%
Anthracycline
14%
PET-CT
14%
Socioeconomic Status
14%
Neutropenia
14%
Cyclophosphamide Plus Doxorubicin Plus Prednisolone Plus Rituximab Plus Vincristine
14%
Age
13%
Infection
11%
Diseases
10%
Drug Resistance
9%
Anaplastic Lymphoma Kinase
9%
Acute Myeloid Leukemia
8%
Hazard Ratio
8%
Comorbidity
8%
MALT Lymphoma
8%
Neoplasm
7%
Disability Pension
6%
Death
5%
T-Cell Lymphoma
5%
International Prognostic Index
5%